Evonik introduces, a unique, non-ionic dispersant especially suited for SC, SE and FS formulations. BREAK-THRU® DA 647 acts as milling aid, wetting agent and dispersant. It also contributes emulsifying properties for aromatic solvents in EC formulations.
BREAK-THRU DA-647 is a versatile molecule, capable of conferring a number of benefits to a variety of pesticide formulations with solid actives.
- During milling, it quickly adsorbs onto solid particles reducing interactions and agglomeration
- Prevents settling and re-agglomeration of particles allowing for formulations with long shelf lives
- No need for co-surfactants
BREAK-THRU DA 647 has a benign toxicological profile with compliance to FIFRA under 40 CFR 180.960. Further information and samples can be requested by contacting our website www.evonik.com/break-thru
Evonik, the creative industrial group from Germany, is one of the world leaders in specialty chemicals, operating in the Nutrition & Care, Resource Efficiency and Performance Materials segments. The company benefits from its innovative prowess and integrated technology platforms. In 2015 more than 33,500 employees generated sales of around €13.5 billion and an operating profit (adjusted EBITDA) of about €2.47 billion.
About Nutrition & Care
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,000 employees, and generated sales of around
€4.9 billion in 2015.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.